Refractory schizophrenia and atypical antipsychotics.

Author: Duncan-McConnellD, TaylorD M

Paper Details 
Original Abstract of the Article :
Treatment resistant or refractory schizophrenia is a difficult to define condition of largely unknown prevalence. For 10 years, clozapine has been the standard treatment in this condition and is recognized unequivocally as being effective. However, clozapine is sometimes poorly tolerated and has the...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/026988110001400411

データ提供:米国国立医学図書館(NLM)

Finding the Right Path for Refractory Schizophrenia

Schizophrenia, a complex and often debilitating mental illness, presents significant challenges for treatment. This review article examines the evidence base for treating refractory schizophrenia, focusing on the use of atypical antipsychotics.

Clozapine: A Beacon of Hope

The review article highlights clozapine as the gold standard treatment for refractory schizophrenia. Despite potential side effects, its efficacy is well-established. The article also discusses the limited evidence for other atypical antipsychotics, suggesting that clozapine remains the most reliable option for managing this challenging condition.

Navigating the Labyrinth of Schizophrenia Treatment

Schizophrenia treatment can be a complex and frustrating journey. This review provides valuable guidance for navigating the different treatment options and understanding the strengths and limitations of each approach. Understanding the evidence base for different medications is crucial for making informed decisions about treatment strategies for individuals with refractory schizophrenia.

Dr. Camel's Conclusion

This review illuminates the challenging landscape of schizophrenia treatment. Like a desert explorer searching for a hidden oasis, researchers are constantly seeking more effective and targeted therapies. Clozapine, like a beacon of hope, stands out as the most reliable treatment for refractory schizophrenia. This review encourages further research into other atypical antipsychotics to improve the lives of individuals living with this complex condition.

Date :
  1. Date Completed 2001-05-31
  2. Date Revised 2017-02-14
Further Info :

Pubmed ID

11198061

DOI: Digital Object Identifier

10.1177/026988110001400411

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.